Follow
Anna Hake
Title
Cited by
Cited by
Year
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ...
Nature 535 (7613), 556-560, 2016
4772016
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
T Schoofs, F Klein, M Braunschweig, EF Kreider, A Feldmann, L Nogueira, ...
Science 352 (6288), 997-1001, 2016
3392016
Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time
A Hake, N Pfeifer
PLoS computational biology 13 (10), e1005789, 2017
332017
Patterns of amino acid conservation in human and animal immunodeficiency viruses
OS Voitenko, A Dhroso, A Feldmann, D Korkin, OV Kalinina
Bioinformatics 32 (17), i685-i692, 2016
102016
From predicting to analyzing HIV-1 resistance to broadly neutralizing antibodies
A Feldmann, N Pfeifer
PeerJ PrePrints, 2015
22015
Dynamics and durability of HIV-1 neutralization are determined by viral replication
P Schommers, DS Kim, M Schlotz, C Kreer, R Eggeling, A Hake, ...
Nature Medicine 29 (11), 2763-2774, 2023
12023
Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed models
A Hake, A Germann, C de Beer, A Thielen, M Däumer, W Preiser, ...
bioRxiv, 2022.07. 06.498925, 2022
12022
Predicting and analyzing HIV-1 adaptation to broadly neutralizing antibodies and the host immune system using machine learning
A Hake
Saarländische Universitäts-und Landesbibliothek, 2022
2022
Predicting HIV-1 Susceptibility to Broadly Neutralizing Antibodies
A Feldmann
Universität des Saarlandes Saarbrücken, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–9